BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2347132)

  • 1. Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation.
    Mielants H; Veys EM; Goethals K; Van Der Straeten C; Ackerman C
    Clin Exp Rheumatol; 1990; 8(1):23-7. PubMed ID: 2347132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical involvement of the gut in undifferentiated spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Clin Exp Rheumatol; 1989; 7(5):499-504. PubMed ID: 2591124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation.
    Mielants H; Veys EM; Goethals K; Van der Straeten C; Ackerman C; Goemaere S
    J Rheumatol; 1990 Mar; 17(3):335-40. PubMed ID: 2332855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Botelberghe L
    J Rheumatol; 1985 Apr; 12(2):294-8. PubMed ID: 3875721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ileocolonoscopic findings in seronegative spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; de Vos M
    Br J Rheumatol; 1988; 27 Suppl 2():95-105. PubMed ID: 3042080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.
    Mielants H; Veys EM; Joos R; Noens L; Cuvelier C; De Vos M
    J Rheumatol; 1987 Jun; 14(3):466-71. PubMed ID: 3498033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation.
    Mielants H; Veys EM; Joos R; Cuvelier C; De Vos M; Proot F
    J Rheumatol; 1987 Jun; 14(3):459-65. PubMed ID: 3498032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Articular diseases and the gut: evidence for a strong relationship between spondylarthropathy and inflammation of the gut in man.
    De Vos M
    Acta Clin Belg; 1990; 45(1):20-4. PubMed ID: 2161601
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation.
    De Keyser F; Van Damme N; De Vos M; Mielants H; Veys EM
    Inflamm Res; 2000 Feb; 49(2):47-54. PubMed ID: 10738942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ileocolonoscopy in seronegative spondylarthropathy.
    De Vos M; Cuvelier C; Mielants H; Veys E; Barbier F; Elewaut A
    Gastroenterology; 1989 Feb; 96(2 Pt 1):339-44. PubMed ID: 2637670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy.
    Cuvelier C; Mielants H; De Vos M; Veys E; Roels H
    Gut; 1990 May; 31(5):545-9. PubMed ID: 2351304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; Maertens M; Joos R
    J Rheumatol; 1993 Sep; 20(9):1567-72. PubMed ID: 8164217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Articular manifestations of inflammatory bowel disease].
    Mauro-Filho Gde L; Ribeiro S
    Arq Gastroenterol; 1985; 22(4):186-91. PubMed ID: 3837658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.